Pangaea Oncology, S.A. (PANG.MC)

EUR 1.7

(1.19%)

Gross Profit Summary of Pangaea Oncology, S.A.

  • Pangaea Oncology, S.A.'s latest annual gross profit in 2023 was 7.75 Million EUR , up 88.55% from previous year.
  • Pangaea Oncology, S.A.'s latest quarterly gross profit in 2023 FY was 7.75 Million EUR , up 88.55% from previous quarter.
  • Pangaea Oncology, S.A. reported a annual gross profit of 4.11 Million EUR in annual gross profit 2022, down -20.49% from previous year.
  • Pangaea Oncology, S.A. reported a annual gross profit of 5.17 Million EUR in annual gross profit 2021, up 12.13% from previous year.
  • Pangaea Oncology, S.A. reported a quarterly gross profit of 1.25 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Pangaea Oncology, S.A. reported a quarterly gross profit of 2.52 Million EUR for 2023 Q3, up 102.19% from previous quarter.

Annual Gross Profit Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Gross Profit of Pangaea Oncology, S.A. (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 7.75 Million EUR 88.55%
2022 4.11 Million EUR -20.49%
2021 5.17 Million EUR 12.13%
2020 4.61 Million EUR 4.62%
2019 4.4 Million EUR 2.76%
2018 4.29 Million EUR 23.52%
2017 3.47 Million EUR -21.23%
2016 4.4 Million EUR 65.31%
2015 2.66 Million EUR 29.93%
2014 2.05 Million EUR -41.04%
2013 3.48 Million EUR 0.0%

Peer Gross Profit Comparison of Pangaea Oncology, S.A.

Name Gross Profit Gross Profit Difference
Clínica Baviera, S.A. 94.98 Million EUR 91.837%